Physician profile
Weitao Wang
NPI 1376960773
$7,397.35
in general payments reported to CMS, 2019-2025
6 companies · $843 in 2025
The $843 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $342 · 2021: $95.09 · 2023: $5,051 · 2024: $677 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,459 · Travel and Lodging: $2,362 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,459.12 |
| Travel and Lodging | $2,362.20 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $3,197.38 | 2023-2024 | |
| Axogen | $1,900.06 | 2023-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Depuy Synthes Sales INC. | $1,555.36 | 2019-2025 | Na, Trumatch, Matrixmandible |
| Stryker Corporation | $570.62 | 2019-2021 | |
| Integra Lifesciences Corporation | $122.77 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kls-Martin L.P. | $51.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weitao Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.